Abbott’s Volt pulsed field ablation system — for the treatment of atrial fibrillation. The Volt system delivers high-energy electrical pulses to targeted areas of the heart to disrupt abnormal rhythms ...

NFL players, coaches and staff put their bodies on the line every season. They sacrifice health, time, energy and more for a chance to win a Super Bowl. When that season eventually comes to an end, it ...

Columbus Regional Health Electrophysiology team completes 500th ablation case for treating irregular heartbeats ...

Jim Harbaugh told reporters Tuesday he had two successful surgeries during the 2025 NFL offseason. One was a hip replacement; the other was a cardiac ablation done after the 61-year-old coach ...

A new technique that involves freezing a patient’s nerves during heart surgery is improving recovery time and reducing the need for heavy painkillers. Dr. David Caparrelli, Chief of Cardiac Surgery at ...

London, United Kingdom – 1 September 2024: Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the ...

Irregular heartbeats, or arrhythmia, can significantly affect a person’s quality of life and overall health. When medication and lifestyle changes are ineffective, doctors may recommend surgery to ...

Doctors perform a number of different outpatient heart procedures, including angioplasty, stenting, pacemaker implantation, and others. If you have a heart condition, your doctor might recommend an ...

Effective treatment of AF is important to enable people to continue to live healthy lives. The most common treatment pathway is medication, including several classes of anti-arrhythmia medication, ...

A doctor may recommend surgery for arrhythmia when medications and lifestyle changes haven’t been effective. The different types of arrhythmia surgeries each aim to restore a regular heart rhythm.

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...